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Neurogenic mechanisms in the pathogenesis of mast cell-driven skin conditions
Martin Metz and Marcus Maurer Department of Dermatology and Allergy, Allergie-Centrum-
Charité, Charité – Universitätsmedizin Berlin
In many inflammatory and pruritic skin conditions, mast cells (MCs) have been identified to be major
contributors to the pathology. In others, for example psoriasis or prurigo nodularis, the contribu-
tion of MC is less clear. There is increasing evidence, however, that the interaction of MC and sen-
sory nerves may be relevant to some extent in all of these diseases. We have known for some time
that there is a close relation of skin MCs and cutaneous sensory nerves (SNs) and that MCs and SNs
share a number of activating signals and mediators, for some of which both cell types express recep-
tors. Of renewed interest in this context is substance P and its role and function in various chronic
inflammatory skin diseases. To this end, we have investigated the role of neuropeptides and their
possible interaction with MCs in clearly defined MC-driven diseases such as urticaria as well as
diseases in which the contribution of MCs is largely unknown, for example prurigo nodularis.
Taken together, our observations and recently published data show that MCs and SNs can work as
functional units in the induction and termination of pruritic inflammatory skin reactions. The bidi-
rectional interaction of MCs and SNs in the induction and control of pruritus and cutaneous inflam-
mation may provide novel therapeutic targets for the treatment of various chronic inflammatory
and pruritic skin diseases. 
Emerging role of alternative splicing in the skin neuroendocrinology
Michal A. Żmijewski Department of Histology, Medical University of Gdansk, Gdansk Poland
Skin is constantly subjected to external and internal stressors, thus it is not surprising that it possess
local and fully functional neuroendocrine system. The skin is respond to the stimuli by local expres-
sion of multiple neuropeptides, cytokines and hormone, which act autocrine, paracrine and at
least in some cases endocrine fashion. Those regulatory molecules may act on target cells thought
the interaction with membrane-bound or nuclear receptors and regulate their proliferation, activ-
ity and immune properties.
The majority of human genes including those for receptors code several protein variants contribut-
ing to the genomic variability. Moreover, recent studies suggest that alternative splicing of mRNA
is an additional level of regulation of the receptor activity. The corticotropin- releasing factor (CRF)
and its receptors (CRF1 and CRF2) are the initiatory elements of hypothalamic-pituitary-adrenal axis
(HPA) – the main central mechanism of stress response. Both CRF receptors were found to be
expressed in various numbers of isoforms in the human and rodent skin. As shown for CRF1 the
pattern of expressed isoforms changes with age of culture and is regulated by environmental fac-
tors such as ultraviolet radiation. As predicted by molecular modeling only some isoforms (CRF1α,
β and c) showed proper cell membrane localization. Others maintained in the cell (CRF1d, f and
g) or were found to be soluble (CRF1e and h). Moreover, presence of alternative isoforms influenced
trafficking, localization and activity of main isoform - CRF1α, as shown of keratinocyte (HaCaT)
model co-expression various CRF1 isoforms. The possible mechanism include dimerization, decrease
of affinity to ligand, modulation of interaction with G-proteins, fast mRNA decay and decoy recep-
tor. Because, alternative splicing of mRNA is common feature of majority of membrane-bound and
nuclear receptors this model may be extended and form additional level of regulation of their activ-
ity. Moreover, neuropeptides and hormones are implicated in the pathogenesis of several human
skin diseases suggesting potential rule of alternative splicing in their development and could rep-
resent an additional target for drugs design.
Recent advances in neurotrophin receptor functions in keratinocytes
Alessandra Marconi and Carlo Pincelli Laboratory of Cutaneous Biology, University of Modena
and Reggio Emilia, Italy
Keratinocytes express the low-affinity p75 neurotrophin receptor (p75NTR) which binds all neu-
rotrophins (NTs), alone or in combination with the high-affinity Tyrosine kinases receptor, TrkA, TrkC
or a truncated form of TrkB. p75NTR was expressed in the basal keratinocyte layer and confined to
transit amplifying cells (TA). Calcium treatment of subconfluent keratinocytes induced the up-reg-
ulation of p75NTR concurrently with the expression of the differentiation markers, while TrkA was
downregulated. p75NTRpos keratinocytes, freshly isolated from TA cells, expressed more survivin
and CK15, while displayed less CK10 and TrkA than p75NTRneg TA. p75NTR retroviral infection
of stem cells induced a more differentiated phenotype with the same features of like TA cells. On
the other hand, when p75NTR was silenced, calcium treatment failed to induce differentiation in
subconfluent keratinocytes. Moreover, β-amyloid, a ligand for p75NTR, induced apoptosis in human
keratinocytes only in p75NTR expressing keratinocytes. BDNF or NT-4, which signal through p75NTR,
determined a higher rate of apoptosis in HaCaT cells overexpressing p75NTR. On the other hand,
NT-4 failed to induce cell death in p75NTRsiRNA transfected HaCaT cells. Because psoriasis is
characterized by a dysregulation of epidermal homeostasis, namely alteration of differentiation
and resistance to apoptosis, we evaluated the expression and function of p75NTR in this disease.
p75NTR was absent in lesional psoriatic skin and p75NTR levels were significantly lower in psori-
atic than in normal TA keratinocytes. The rate of apoptosis in psoriatic TA cells was significantly
lower, as compared to normal TA cells. p75NTR retroviral infection restored apoptosis in psoriatic
keratinocytes. These results suggest that p75NTR has a dual role: it acts as a “switch on-off” in dif-
ferentiation and/or as a pro-apoptotic receptor. Thus, p75NTR is essential for maintaining epider-
mal homeostasis. 
Serotonergic mechanisms in atopic dermatitis
Klas Nordlind, Husameldin El-Nour, Sol-Britt Lonne-Rahm and Aram Rasul Department of
Medicine, Solna, Dermatology and Venereology Unit, Karolinska Institutet, Stockholm, Sweden
Atopic dermatitis is a severely itching chronic inflammatory disease. Patients with atopic dermati-
tis have been suggested to have a changed personality and being phrone to have increased stress
susceptibility and anxiety. Serotonin (5-hydroxytryptamin; 5-HT) is an important neuromediator
being involved in anxiety and stress susceptibility.
In the present study 28 patients with atopic dermatitis have been characterized regarding extent of
the disease (SCORAD), pruritus, depression, chronic stress, and personality traits, being correlated
with expression of serotonergic markers, 5-HT and its receptors 5-HT1A and 5-HT2A, and sero-
tonin transporter protein (SERT), in involved (bend of the arm) and non-involved (lower back) skin,
by immunohistochemistry. Expression of 5-HT1AR was found in the upper part of the epidermis, as
well as on melanocytes and dermal inflammatory cells. The number of such dermal inflammatory
cells in the involved skin correlated with SCORAD values. 5-HT2AR expression was found in the
epidermis, on the basal membrane and vessel walls. In the non-involved skin the vessel expression
of 5-HT2AR correlated with SCORAD. SERT was expressed in dendritic cells in the epidermis and
the dermis and also in the basal layer of the epidermis. The stronger the basal epidermal immunore-
activity for SERT in the involved skin the less degree of stress susceptibility and chronic stress. These
results indicate that serotonergic mechanisms are involved in atopic dermatitis.
Itch and pain: Psychophysiological mechanisms and therapeutic strategies
Andrea W.M. Evers Radboud University Medical Centre Nijmegen, The Netherlands 
The complex mechanisms of acute and chronic pain, for example due to sensitization of nocicep-
tors, have been studied extensively. In contrast, research on itch has received far less attention, while
itch shares common neurophysiological and psychophysiological processes with pain. In this lec-
ture, recent evidence on the similarities and differences between itch and pain will be discussed
on a psychophysiological level, with a focus on both mechanisms and therapeutic strategies. Specif-
ically, an overview about recent psychophysiological studies will be given, including sensory, cog-
nitive, behavioral and affective factors, demonstrating both common and distinctive psychophysi-
ological mechanisms and therapeutic strategies for chronic itch and pain. Implications for possible
common therapeutic strategies will be discussed.
The influence of disease on Major Life Changing Decisions
Andrew Y Finlay1, Zaheer U Bhatti1,2, M Sam Salek2 1 Department of Dermatology and Wound
Healing, School of Medicine, Cardiff University, Cardiff, UK 2 Centre for Socioeconomic
Research, School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK
Skin disease can have a great impact on current quality of life, but it can also have a profound long-
term impact on the course of a patient’s life.  Everyone takes a number of Major Life Changing
Decisions (MLCD) concerning for example which career to follow, or whether to have children.  If
these are influenced by having a skin disease, this influence will echo down that person’s life: such
influences are not confined to skin disease but occur across all aspects of medicine.  We have under-
taken a detailed literature review of MLCDs and have suggested that MLCDs are integral to cumu-
lative life course impairment.
In order to understand the range of MLCDs influenced by disease of skin or other organs we inter-
viewed dermatology patients (n=50), and patients with chronic disease from the rheumatology,
diabetes, cardiology, pulmonary and renal clinics completed questionnaires (n=310).   NVivo8
software was used to assist the qualitative analysis.
Career choice (66%) and job (58%) were the most commonly reported MLCDs influenced by skin
disease.  In the other patients, the most frequently reported concerned early retirement (41%), impact
on job (29%), having children (25%), career choice (22%) and relationships (16%).   41 affected
MLCDs were identified and grouped into 15 categories.  Amongst the dermatology patients the
mean number of affected MLCDs was 5.5.  Amongst the other specialities, the mean number was
highest in patients with cystic fibrosis and lowest in nephrology patients.
A definition of  “MLCD” was proposed based on this analysis, and a MLCD Profile is being created
and validated based on the findings of the study.  There is a large impact of skin and other diseases
on MLCDs.  This has important clinical implications: timely pro-active counselling of patients may
potentially assist patients to take appropriate MLCDs, and hence reduce the long-term burden of
chronic disease.
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